DAVID W GRYSKA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID W GRYSKA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID W GRYSKA. DAVID W GRYSKA is an Executive Vice President, CFO in INCYTE CORP ($INCY) and a Director in PDL BIOPHARMA, INC. ($PDLI) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in COTHERIX INC ($CTRX) and a Director in AERIE PHARMACEUTICALS INC ($AERI) and a Director in GW PHARMACEUTICALS PLC ($GWPH).
Address: 5000 SHORELINE COURT SUITE 101 SOUTH SAN FRANCISCO 94080 CA
Companies in which DAVID W GRYSKA is an Insider
AERIE PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID W GRYSKA: Director
Holdings: 3,500 shares
Current Value: $149,800
Latest Transaction: Jun 29 2020
$AERI Market Capitalization: $1.50B
$AERI Previous Close: $42.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
COTHERIX INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID W GRYSKA: Director
Holdings: 0 shares
Latest Transaction: May 26 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GW PHARMACEUTICALS PLC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID W GRYSKA: Director
Holdings: 0 shares
Latest Transaction: Feb 24 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INCYTE CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of DAVID W GRYSKA: Executive Vice President, CFO
Holdings: 10,235 shares
Current Value: $1,209,572
Latest Transaction: Jul 18 2018
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PDL BIOPHARMA, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID W GRYSKA: Director
Holdings: 1,387 shares
Current Value: $3,065
Latest Transaction: Dec 31 2020
$PDLI Market Capitalization: $367.50M
$PDLI Previous Close: $2.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID W GRYSKA: Director
Holdings: 46,250 shares
Current Value: $2,811,538
Latest Transaction: May 18 2021
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DAVID W GRYSKA
Sentiment: All, AERI, CTRX, GWPH, INCY, PDLI, SGEN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2021 | SGEN | Seagen Inc. | GRYSKA DAVID W | Director | Option Exercise | A | 147.50 | 3,462 | 510,645 | 3,462 | |
| May 18 2021 | SGEN | Seagen Inc. | GRYSKA DAVID W | Director | Grant | A | 0.00 | 1,402 | 0 | 46,250 | 44.8 K to 46.3 K (+3.13 %) |
| Feb 24 2021 | GWPH | GW PHARMACEUTICALS ... | GRYSKA DAVID W | Director | Option Exercise | A | 0.00 | 22,464 | 31 | 22,464 | |
| Dec 31 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.74 | 20,000 | 54,800 | 1,387 | 21.4 K to 1.4 K (-93.51 %) |
| Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.68 | 75,000 | 201,000 | 21,387 | 96.4 K to 21.4 K (-77.81 %) |
| Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.68 | 75,000 | 201,000 | 21,387 | 96.4 K to 21.4 K (-77.81 %) |
| Dec 04 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.52 | 75,000 | 189,000 | 30,337 | 105.3 K to 30.3 K (-71.20 %) |